Lynx1 Capital Management LP

Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: +$21.1M

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
KRRO	Korro Bio, Inc.	$84.3K	$0	+$84.3K	1.5M	Aug 10
PASG	Passage BIO, Inc.	$1.2M	$0	+$1.2M	673,759	Jun 25
TCRX	TScan Therapeutics, Inc.	$3.3M	$0	+$3.3M	8M	Dec 23, 2025
CGEM	Cullinan Therapeutics, Inc.	$13.3M	$0	+$13.3M	9M	Oct 28, 2025
NEUP	Neuphoria Therapeutics Inc.	$3.3M	$0	+$3.3M	875,328	Oct 21, 2025

Korro Bio, Inc.

+$84.3K

Bought

$84.3K

Sold

Held

1.5M

Passage BIO, Inc.

+$1.2M

Bought

$1.2M

Sold

Held

673,759

TScan Therapeutics, Inc.

+$3.3M

Bought

$3.3M

Sold

Held

Cullinan Therapeutics, Inc.

+$13.3M

Bought

$13.3M

How quickly this filer reports. Section 16 allows two business days from the transaction.

2 of 11 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 3 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Company	Past deadline	Largest line	Source
Aug 6	Aug 13	KRROKorro Bio, Inc.	3days	$59.5K	Filing ↗
Oct 14, 2025	Oct 20, 2025	CGEMCullinan Therapeutics, Inc.	2days	$1.3M	Filing ↗

Korro Bio, Inc.

The 24 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Aug 10	KRRO	Korro Bio, Inc.	PBUY	1,462	$13.19	$19.3K	+<0.1%	Open the original filing on SEC.gov
Aug 6	KRRO	Korro Bio, Inc.	PBUY	5,222	$11.40	$59.5K	+0.3%	Open the original filing on SEC.gov
Jun 25